X-RAY AND MRI RESULTS FROM A PHASE IIB STUDY OF SUBCUTANEOUS ANTI-INTERLEUKIN-6 MONOCLONAL ANTIBODY CLAZAKIZUMAB WITH OR WITHOUT MTX IN ADULTS WITH MODERATE-TO-SEVERE ACTIVE RA AND INADEQUATE RESPONSE TO CONVENTIONAL DMARDS INCLUDING METHOTREXATE
Author(s):
; Pellas, T.; Heijde, D. van der; Weinblatt, M.; Emery, P.; Zilberstein, M.; Conaghan, P.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, p. 665-666
